These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10741742)

  • 1. Microsatellite alterations plasma DNA of primary breast cancer patients.
    Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
    Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H; Müller V; Stahmann N; Pantel K
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
    Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
    Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
    Goessl C; Heicappell R; Münker R; Anker P; Stroun M; Krause H; Müller M; Miller K
    Cancer Res; 1998 Oct; 58(20):4728-32. PubMed ID: 9788629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
    Silva JM; Dominguez G; Garcia JM; Gonzalez R; Villanueva MJ; Navarro F; Provencio M; San Martin S; España P; Bonilla F
    Cancer Res; 1999 Jul; 59(13):3251-6. PubMed ID: 10397273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
    Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
    Li BJ; Huang XP; Wei WD; Wang JY; Su XD; Zhang X; Hong WS; Tang J; Zhang LJ; Long H; Yang MT; Rong TH
    Ai Zheng; 2005 Jun; 24(6):735-9. PubMed ID: 15946491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular tumor DNA in plasma and overall survival in breast cancer patients.
    Garcia JM; Garcia V; Silva J; Peña C; Dominguez G; Sanchez A; Sanfrutos L; Provencio M; Millan I; Chaparro D; España P; Bonilla F
    Genes Chromosomes Cancer; 2006 Jul; 45(7):692-701. PubMed ID: 16607614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.
    Schwarzenbach H; Eichelser C; Kropidlowski J; Janni W; Rack B; Pantel K
    Clin Cancer Res; 2012 Oct; 18(20):5719-30. PubMed ID: 23014523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite alterations in serum DNA of patients with colorectal cancer.
    Kölble K; Ullrich OM; Pidde H; Barthel B; Diermann J; Rudolph B; Dietel M; Schlag PM; Scherneck S
    Lab Invest; 1999 Sep; 79(9):1145-50. PubMed ID: 10496533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
    Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
    Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.
    Nowacka-Zawisza M; Bryś M; Hanna RM; Zadrozny M; Kulig A; Krajewska WM
    Pol J Pathol; 2006; 57(2):83-9. PubMed ID: 17019970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.